SHANE WILBURN: Open Payments
NPI 1669178075 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 25 payments from 9 companies in 2025. Trend: 2023 $122 · 2024 $1,105 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $231 |
| Amgen Inc. | 6 | $116 |
| Novo Nordisk Inc | 4 | $87 |
| PFIZER INC. | 3 | $66 |
| Corcept Therapeutics | 2 | $49 |
| Seqirus USA Inc | 2 | $38 |
| ABBVIE INC. | 2 | $34 |
| SANOFI-AVENTIS U.S. LLC | 1 | $34 |
| Daiichi Sankyo Inc. | 1 | $19 |
Products named: BREZTRI, OTEZLA, FARXIGA, PREVNAR 20, Korlym, Ozempic, Flucelvax, VRAYLAR.
Industry payments across SC — which companies pay providers there.
